Cyclerion Therapeutics, Inc. (CYCN) has 15 open-market insider trades by 6 insiders since 2019. The most active filer is Mark G. Currie, President & CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Terrance McGuire | Dir | — | 3 | $10.6M | 2023-11-30 |
| Amy W. Schulman | Dir | — | 1 | $10.0M | 2019-04-08 |
| Peter M. Hecht | CEO | — | 3 | $8.8M | 2025-03-25 |
| Mark G. Currie | PresCSO | — | 4 | $8.3M | 2020-12-28 |
| David Gerald Greenspan | 10% Owner | — | 2 | $6.6M | 2024-11-21 |
| Andreas Busch | — | — | 2 | $544K | 2020-11-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Gerald Greenspan | 10% Owner | Sell | $555K | 2024-11-21 |
| Terrance McGuire | Director | Sell | $27 | 2023-08-09 |
| Terrance McGuire | Director | Buy | $590K | 2021-06-03 |
| Peter M. Hecht | CEO | Buy | $5.4M | 2021-06-03 |
| David Gerald Greenspan | 10% Owner | Buy | $6.0M | 2021-06-03 |
| Peter M. Hecht | CEO | Buy | $734K | 2021-05-06 |
Companies that share insiders with CYCN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Peter M. Hecht | CEO | Buy | $2.7M | 2021-05-04 |
| Anjeza Gjino | CFO | Sell | $7K | 2021-02-25 |
| Christopher I. Wright | Chief Medical Officer | Sell | $11K | 2021-02-25 |
| Mark G. Currie | President & CSO | Sell | $121K | 2020-12-28 |
| Andreas Busch | — | Buy | $316K | 2020-11-09 |
| William Huyett | CFO | Sell | $10K | 2020-11-06 |
| William Huyett | CFO | Sell | $18K | 2020-02-21 |
| Mark G. Currie | President | Sell | $190K | 2019-12-27 |
| Andreas Busch | — | Buy | $228K | 2019-11-15 |